TrialCardiovascular therapeutics2016

Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk.

Jay L Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.